Surrozen Company
Surrozen is pioneering target regenerative antibodies to repair a broad range of tissues and restore organs damaged by serious disease. Surrozen’s uniquely-engineered antibodies are designed to selectively modulate the Wnt pathway to repair tissue damaged by these and other diseases, and to improve organ function.
Industry:
Small&Large Molecules
Headquarters:
California, United States
Register and Claim Ownership